医学
间质性肺病
支气管痉挛
肺纤维化
药品
肺
疾病
肺水肿
重症监护医学
内科学
病理
药理学
哮喘
作者
Martin Schwaiblmair,Werner Behr,Thomas Haeckel,Bruno Märkl,Wolfgang Foerg,Thomas Berghaus
标识
DOI:10.2174/1874306401206010063
摘要
With an increasing number of therapeutic drugs, the list of drugs that is responsible for severe pulmonary disease also grows. Many drugs have been associated with pulmonary complications of various types, including interstitial inflammation and fibrosis, bronchospasm, pulmonary edema, and pleural effusions. Drug-induced interstitial lung disease (DILD) can be caused by chemotherapeutic agents, antibiotics, antiarrhythmic drugs, and immunosuppressive agents. There are no distinct physiologic, radiographic or pathologic patterns of DILD, and the diagnosis is usually made when a patient with interstitial lung disease (ILD) is exposed to a medication known to result in lung disease. Other causes of ILD must be excluded. Treatment is avoidance of further exposure and systemic corticosteroids in patients with progressive or disabling disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI